peer-reviewed-study-finds-pfizer-vaccine-impairs-semen-concentration-and-total-motile-count-also-shows-1-in-5-men-had-motility-count-drop-to-zero

Peer-Reviewed Study Finds Pfizer ‘Vaccine’ Impairs Semen Concentration and Total Motile Count


A new peer-reviewed study published in the journal Andrology finds that the Pfizer “vaccine” impairs semen concentration and total motile count, as well as a possible drop in motility count to zero in one in five men.


Despite so-called “fact-checkers'” claims that there is “No evidence that COVID-19 vaccination negatively impacts male fertility,” a new study published in the journal Andrology (June 17, 2022) has found the injections do exactly that. The study, which has a relatively rosy conclusion considering its actual findings, shows that, post “vaccination” with the Pfizer injection, men experience a persistent decline of approximately 16% in sperm concentration and about 20% in total motile count at the six-month mark. And, possibly, permanently.

The study, titled “Covid-19 Vaccination BNT162b2 Temporarily Impairs Semen Concentration and Total Motile Count among Semen Donors,” was authored by Itai Gat, an MD at the Sperm Bank & Andrology Unit, IVF Department, Shamir Medical Center, in Israel, et al. and looked at 220 samples from 37 sperm donors (from three separate sperm banks). Samples were collected prior to “vaccination (at T0), as well as at intervals T1 (26.7±10 days after injection), T2 ( 92.5±13.4 days after injection), and T3 (174.8±26.8 days after injection).

Image: Itai Gat et al. / Andrology (highlights and border added by SRN)

“No significant change was demonstrated between T1 and T0,” the authors report in their study. “However, while volume and motility changes on T2 were not significant, sperm concentration was significantly lower due to decrease of -15.4% (confidence interval -25.5%–3.9%) compared to T0 (p=0.01),” they add. “Moreover, TMC (total motility count) percentage change reduction of 22.1% was significantly lower compared to T0 (confidence interval -35% –6.6%, p=0.007) as well. Although concentration and TMC were reduced also on T3, these values did not reach statistical significance… .”

The authors go on to say that “Last and similarly, median differences between T1, T2 and T3 vs.T0 according to sample’s mean of each donor were investigated. Again, the only significant differences were found specifically on sperm concentration and TMC on T2–median decline of 9.5 million/ml and 27.3 million motile spermatozoa, respectively (p=0.004 and 0.003, respectively) followed by recovery on T3.”

“[T]he long-term impact of BNT162b2 vaccine seems safe,” the authors conclude (italics SRN’s). “To the best of our knowledge, this is the first longitudinal research that continuously examined semen analysis after vaccination over 6 months—beyond the spermatogenesis period in human.”

As for a mechanism of action, the authors note that “Various testicular cells including Leydig, Sertoli, spermatogonia and spermatozoa express ACE2…, “ which is the receptor the spike protein—either produced by the virus or the injections—binds with. (Incidentally, note that Dr. Ralph Baric et al. explicitly stated in a study in 2016 published in the journal PNAS—and funded by Tony Fauci’s NIAID—that they had created “chimeric and full-length zoonotic coronaviruses to evaluate emergence potential” and that they tested their engineered chimeric viruses in human airway cultures and in vivo in mice with Humanized ACE2 receptors.)

The injections—including Pfizer’s, Moderna’s, and Johnson & Johnson’s—of course, include the mRNA code (or the DNA code in the case of J&J’s) for the original Wuhan virus’ spike protein. Meaning if the spike protein of the SARS-CoV-2 virus can “dock” with a human cell, it only makes sense that the replication spike proteins produced by the injections—which are necessarily genetically identical to the real thing—would as well.

The authors’ explanation for this drop in sperm concentration and TMC is, however, a “systemic immune response” after injection with the Pfizer “vaccine,” and they claim the response is “a reasonable cause for transient semen concentration and TMC decline.” They add that “Long-term prognosis [for semen quality and quantity] remains good.”

Despite the authors’ claims, however, Israeli “data-maven” Ran Israeli noted in a tweet (immediately above)—which comes via the legendary researcher el gato malo—that it “Seems like the authors took advantage of the Median vs Average differences to suggest that everything was fine 150 days after vaccination.” This, however, is not the case according to the data from the study’s tables.

Indeed, el gato malo—a seasoned COVID researcher in his own right—noted in a June 19, 2022 Substack post that “if somewhere on the order of 1 in 5 and 2 in 5 males are seeing severe, durable drops in TMC (50-100% drop), that’s a massive side effect profile. (4 in 10 dropping 50% has the same effect on the avg as 2 in 10 dropping 100%)[.]” The men who had their motility drop to zero—which occurred in one in five men—“were sterilized” el gato malo claims.

The spike protein produced by the injections making its way to the testes would make sense, as a pharmacokinetics study performed by Japanese researchers—in which they looked at where in the body lipid nanoparticles (or the little “bubbles of fat” that contain the mRNA code for the spike protein) go—found they do distribute to the ovaries. Although the study, which was performed on mice and rats, found that less than 1% of the lipid nanoparticles go to the ovaries.


Feature image: Internet Archive Book Images

(Visited 25 times, 20 visits today)

Accessibility Toolbar